Delivery Order SPE2DB24D2101-SPE2DB25FKLMP
Award Date 6/17/25
Potential Completion Date 6/18/25
Potential Value $2.8K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,362.96 to AmerisourceBergen Drug Corp for the supply of Insulin Aspart 100 Unit/ML pens (3ML) with a firm fixed price structure. The award was made on September 11, 2025, with an ultimate completion date of September 12, 2025, and is not designated as a set-aside contract. This delivery order represents a competitive award exercised under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $1,300.68 to AmerisourceBergen Drug Corp for the supply of Insulin Aspart 100 Unit/mL pens (3mL) under a firm fixed price contract. The award was made on September 17, 2025, with an ultimate completion date of September 18, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This delivery order represents a non-set-aside, competitively awarded transaction and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Insulin Aspart 100 Unit/ML pens (3ML) with a ceiling value of $9,672.58. This firm fixed price delivery order, which is not associated with a set-aside program, represents a competitive procurement to support federal medical supply needs. The order is scheduled for completion by August 14, 2025, and will be fulfilled from AmerisourceBergen's corporate office located in...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Insulin Aspart 100 Unit/mL pens (3mL) under a firm fixed-price contract with a ceiling value of $1,865.96. This non-set-aside delivery order is scheduled for completion by September 11, 2025, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of the company's role as a...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $1,385.42 on August 19, 2025, for the supply of Insulin Aspart 100 Unit/mL vials (10mL). This firm fixed-price delivery order, with an ultimate completion date of August 20, 2025, represents a child contract under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical. The award was made through competitive procurement with no set-aside designation. The place of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Insulin Aspart 100 Unit/mL pens in 3mL quantities, valued at $21,585.35. This non-set-aside, competitively awarded delivery order carries a firm fixed price and is scheduled for completion by September 15, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a continuation of...
- The U.S. Department of Defense's Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $1,463.20 for Insulin Aspart 100 Unit/mL vials (10mL) on July 18, 2025, with an ultimate completion date of July 21, 2025. This firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award is issued as a child contract under AmerisourceBergen's existing Indefinite...
- The Department of Defense's Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The contract, valued at $2,195.52, is for the provision of Insulin Aspart 100 unit/mL pens with a completion date of January 31, 2024. Amerisourcebergen Drug Corp serves as the prime contractor on this delivery order, which is part of a larger indefinite delivery...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on September 8, 2025, for the supply of Insulin Lispro 100 Unit/ML pens (3ML) with a ceiling value of $1,358.28. This is a firm fixed price, non-set-aside contract with an ultimate completion date of September 9, 2025, and is being funded through the Medical Supply Chain, a defense-oriented federal agency. The contract represents a child delivery order under...
- The Defense Logistics Agency awarded a $1,023.75 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Insulin Aspart 100 Unit/mL vials (10 mL) on July 14, 2025, with an ultimate completion date of July 15, 2025. This non-set-aside competitive award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle running through December 2026. The place of...